Sterile lancets are single-use disposable needles that are majorly used for blood sampling by perforating the skin. Moreover, these lancets can be used independently as safety lancet or can be used with the lancing device that holds the lancet while perforating the skin.
Sterile lancets are majorly utilized for checking blood glucose level in diabetic patients, however they lancets are also used for collecting blood samples to perform other diagnostic tests. Furthermore, skin testing for allergies can be performed using sterile lancets. Sterile lancets offers safety against accidental injuries and contamination.
Get Sample Report with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/1994
Sterile Lancets Market – Dynamics
The growth of the sterile lancet market is attributed to increasing prevalence of diabetes across the globe. For instance, according to the International Diabetes Federation’s (IDF) Diabetes Atlas 2017, around 425 million patients were suffering from diabetes globally by end of 2017 and it the number is estimated to increase and reach around 629 million by 2045. Moreover, over 40% people suffering from diabetes are still undiagnosed, especially in regions such as Asia Pacific, Middle East and some part of North Africa. These patients would require insulin therapy, which is further expected to fuel demand for sterile lancets, thereby propelling growth of the sterile lancets market.
In addition, according to the World Health Organization (WHO) 2012 factsheet, diabetes is one of the top three causes of death amongst non-communicable diseases. This is attributed to sedentary lifestyle, and obesity. Moreover, rising geriatric population, across the globe is another factor that is expected to fuel the sterile lancet market growth, as older people often require continuous glucose monitoring due to growing incidence of uncontrolled diabetes. For instance, according to the estimation by International Diabetes Federation (IDF), in 2017, there were around 98 million diabetic people, across the globe who were above the age of 65 years, and this is further projected to increase to reach around 191 million by 2045.
Additionally, increasing demand for safe injection practices to collect blood is expected to drive demand for sterile lancets, as it avoids the risk of contamination by blood-borne pathogens. For instance, according to a report published by the World Health Organization (WHO) in 2014, around 1.7 million people were reported to be infected with hepatitis B virus, around 315,000 with hepatitis C virus, and around 33,800 with HIV, owing to unsafe injection practices.
Major market players are focusing on offering novel products, which is expected to drive growth of the sterile lancets market over the forecast period. For instance, Becton, Dickinson and Company offer BD Microtainer Contact-activated Lancet, which aids in easier blood sampling and covers a small area at contact point that further enhances visibility of the desired puncture site activated only on pressure application to lancet.
Sterile Lancets Market – Regional Insights
Among regions, North America is expected to hold dominant position in the global sterile lancets market over the forecast period, owing to rising prevalence of diabetes in the region. For instance, according to the International Diabetes Federation (IDF), highest prevalence of diabetes (13% of population) is observed in the U.S.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1994
Moreover, North America accounts for highest expenditure on diabetes. For instance, according to the IDF report 2017, the U.S. spends around US$ 377 billion annually over diabetes disease treatment, which accounts for around 52% of the total expenditure on diabetes worldwide. Furthermore, there are 30.3 million people suffering from diabetes in the U.S. (9.4% of the US population), which includes 23.1 million people who are diagnosed and 7.2 million people who are undiagnosed.
Asia Pacific is estimated to exhibit highest CAGR and is further expected to create lucrative growth opportunities in the sterile lancet market over the forecast period, owing to highest number of diabetes patients in the region. For instance, according to the IDF data, countries such as China (114.4 million) and India (72.9 million)) are amongst the top three economies, exhibiting high prevalence of diabetes. Asia Pacific had over 240 million diabetes patients in 2017.
Europe is another lucrative region for the market, as it currently has the highest type1 diabetes population and the highest percentage of geriatric populace.
Sterile Lancets Market – Competitive Landscape
Major players operating in the sterile lancet market include Becton, Dickinson and Company, F-Hoffmann La Roche AG, Nipro Corporation, Ypsomed AG, Sanofi, Abbott Healthcare, B. Braun Melsungen AG, Sarstedt AG & Co., Terumo Corporation, Medtronic plc., Greiner Bio One, Jiangsu Huida Medical Instruments Co. Ltd., Allison Medical, Inc., and A. Menarini Diagnostics
Sterile Lancets Market – Market Taxonomy
On the basis of product type, the global sterile lancets market is segmented into:
-
Conventional Sterile Lancets
-
Safety Sterile Lancets
On the basis of application, the global sterile lancets market is segmented into:
-
Diabetes
-
Others
On the basis of distribution channel, the global sterile lancets market is segmented into:
-
Retail Pharmacies
-
Hospital Pharmacies
-
Online Pharmacies
On the basis of region, the global sterile lancets market is segmented into:
-
North America
-
Latin America
-
Europe
-
Asia Pacific
-
Middle East
-
Africa
Purchase This Premium Report Here To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/1994
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837